BRD2 and infection: CLIA exhibited higher reactivity rates than NAT for all infections:HIV (0.4%, 122/1,843 vs. 0.06%, 18/1,843), HBV (3.0%, 904/1,843 vs. 1.7%, 507/1,843) and HCV (1.4%, 421/1,843 vs. 0.6%, 176/1,843) oftotal donations, indicating a higher false positive rate shown in Table 2 (see PDF) and Figure 2 (see PDF).